Schedule 13D ownership disclosure
ESSA PHARMA INC
Security class unavailable · CUSIP: 29668H708
Event date: 2019-05-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,385,970
- Percent of class
- 19.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001580642-19-002593
- Form type
- SC 13D
- Filer
- ESSA Pharma Inc.
- CIK
- CIK 1633932
- Filed
- May 23, 2019
- Reporting period
- May 14, 2019
- Description
- Schedule 13D beneficial ownership